Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence
about
Group B streptococci inactivate complement component C5a by enzymic cleavage at the C-terminusImmunochemical analysis and immunogenicity of the type II group B streptococcal capsular polysaccharide.Genetic polymorphisms of group B streptococcus scpB alter functional activity of a cell-associated peptidase that inactivates C5a.Interaction of group B streptococcal opacity variants with the host defense system.Group B streptococcal infection: a review and update.Enzyme-linked immunosorbent assay for group B streptococcal antibodies.Influence of complement on the chemiluminescent response of human leukocytes to immune complex.Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases.Antibody against surface-bound C5a peptidase is opsonic and initiates macrophage killing of group B streptococci.Chicken embryo model for type III group B beta-hemolytic streptococcal septicemia.Strain specificity of opsonins for group B streptococci types II and III.Group B streptococcal type Ia sepsis in mice after intranasal inoculation and the effect of infection on lungsPurification and partial characterization of neuraminidase from type III group B streptococci.Group B streptococcal long-chain reaction.Role of antibody and complement in opsonization of group B streptococci.Peritoneal macrophage activation indicated by enhanced chemiluminescence.In vitro evaluation of opsonic and cellular granulocyte function by luminol-dependent chemiluminescence: utility in patients with severe neutropenia and cellular deficiency statesEffect of chemoattractants on chemiluminescence.Preterm infants have deficient monocyte and lymphocyte cytokine responses to group B streptococcusPenicillin-binding protein 1a promotes resistance of group B streptococcus to antimicrobial peptides.Hypersusceptibility of penicillin-treated group B streptococci to bactericidal activity of human polymorphonuclear leukocytesVariations in the opsonic requirements of group B streptococcus type III.Group B streptococcal opacity variants.Type-specific protection of neonatal rats from lethal group B streptococcal infection by immune sera obtained from human volunteers vaccinated with type III-specific polysaccharide.The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B StreptococcusQuantitation of in vitro opsonic activity of human antibody induced by a vaccine consisting of the type III-specific polysaccharide of group B streptococcus.Fibronectin enhances the opsonic and protective activity of monoclonal and polyclonal antibody against group B streptococci.Antibody to group B Streptococcus type III in human sera measured by a mouse protection test.Group B, type III streptococcal cell wall: composition and structural aspects revealed through endo-N-acetylmuramidase-catalyzed hydrolysis.Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assayEffects of route and time of administration of antiserum on protection of mice from lethal infection due to group B Streptococcus type IIIImmunomodulation by Blastomyces dermatitidis: functional activity of murine peritoneal macrophages.Opsonization of Streptococcus agalactiae of bovine origin by complement and antibodies against group B polysaccharidePathogenesis of neonatal group B streptococcal infectionsAntibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.Antibody-independent and -dependent opsonization of group B Streptococcus requires the first component of complement C1Chemiluminescence of human and canine polymorphonuclear leukocytes in the absence of phagocytosis.Type-specific capsular antigen is associated with virulence in late-onset group B Streptococcal type III diseaseClass specificity of naturally acquired and vaccine-induced antibody to type III group B streptococcal capsular polysaccharide: determination with a radioimmunoprecipitin assayIsolation, chemical composition, and molecular size of extracellular type II and type Ia polysaccharides of group B streptococci.
P2860
Q24529541-AA2824A3-1F38-4C83-A0A5-034778195A2CQ28365895-F8692F1D-A40A-46A9-97A4-097F5C0D0571Q33598236-E6DC72BE-08B2-4208-859C-A14A49D4DC74Q33607847-52EDCF3C-8073-4143-BA17-DB933EC82940Q33656362-B62B5BE6-0AB5-42C7-8A80-36D93B447615Q33897966-D8B3A485-BD1D-4207-865B-B48309ACA82CQ33905912-1F5C0741-C3A2-42A3-9A8B-FC12E338CC32Q33999369-B2C90E9A-34B1-4DE9-8DE3-A9FB2D0E5A26Q34006819-0B94A4BA-D7CE-4C9E-8883-1DB91B9BA2F7Q34076578-B3D5BB20-E721-48DC-BB5A-4FBAF262313CQ34078837-C5DC6216-8824-47ED-8A51-AC723151A46BQ34095373-32B79A56-562B-46D0-9BDB-52A69A6387F3Q34157435-5CFF16B6-4259-4057-B06A-19AAC4BAAD79Q34420297-4050D31A-962D-44BE-9DFF-F3C8EDA2E778Q34449325-C7DEF153-328E-4FF0-80BC-2ED8F57FD864Q34455436-DF3DD6E2-77E2-411A-B87F-A69D21CCD69FQ34456745-113C2907-9D51-4620-AF10-AC6E7E7EFBE3Q34464368-744A501E-7843-4B57-B4AA-8D37EECFEBF7Q34740184-FC80C6B7-85FA-4E4C-886D-CEDCDFBADF8AQ35217549-9208C3E2-ADE0-444C-BB86-D1196724983EQ35669554-E2CAC953-CBD9-4575-BA7F-D039218654C9Q36091664-BD7BA8B9-0C49-4EC9-90BF-75445431EDB2Q36112170-C8D84C33-DA9B-4EC2-8A0B-2D331B41AD2CQ36332961-49A29DFA-3407-4E4D-BCFA-440F25B0FE42Q36343590-AB2EA145-87E9-449B-B185-2D7433AEF375Q36346039-0F9CE8BF-0404-4541-B922-34ED9BE48EE2Q36348820-84512D2B-6FA9-4175-AED5-252620ED91C3Q36421902-86BEE08E-B269-4230-BCCC-0767E41B579FQ36435978-91978973-2EF7-4E33-96D3-98CE0CDE62DFQ36454624-BC6FFA55-0DB7-4100-977E-32D522EC2AE9Q36455255-5906E00E-0E43-460C-A752-9F4250452695Q36632894-E3F7C1E3-A1B7-4EE0-BF9B-1047091F2A39Q36971152-623B3249-5709-4FA1-8CC1-12877FD169A6Q37000307-E9BC8A4A-BDEE-4A01-89AC-3567CD427A07Q37007743-33CAEC3A-AFEB-4D24-8875-6371700FC02BQ37050674-2F44CB5A-2B25-419D-8ABC-B286D0AF15B8Q37053416-CB224DA2-8819-4D5B-BC75-C86362502E24Q37081296-2D58695A-25F1-45CE-ACD9-792FD772522FQ37082066-0241BA7D-AE85-4275-8844-91539A62C536Q37107158-7C3A0917-C273-4E64-986D-1BA4F04E82D2
P2860
Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
1976年论文
@zh
1976年论文
@zh-cn
name
Assessment of group B streptoc ...... y neutrophil chemiluminescence
@ast
Assessment of group B streptoc ...... y neutrophil chemiluminescence
@en
type
label
Assessment of group B streptoc ...... y neutrophil chemiluminescence
@ast
Assessment of group B streptoc ...... y neutrophil chemiluminescence
@en
prefLabel
Assessment of group B streptoc ...... y neutrophil chemiluminescence
@ast
Assessment of group B streptoc ...... y neutrophil chemiluminescence
@en
P2093
P2860
P356
P1476
Assessment of group B streptoc ...... y neutrophil chemiluminescence
@en
P2093
P2860
P304
P356
10.1172/JCI108593
P407
P577
1976-12-01T00:00:00Z